Digital Health Acquisition Corp.
NASDAQ:DHAC
12.1099 (USD) • At close June 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.354 | 1.712 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.941 | 0.487 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 2.413 | 1.225 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.719 | 0.716 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 2.17 | 0.509 | 0.674 | 2.593 | 0 | 0 | 0.001 | 2.395 | 1.129 | 0.722 | 0.543 | 0.277 | 0 | 0.005 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -1.149 | 0 | 0.442 | 0.707 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.17 | 0.509 | 0.674 | 0.926 | 0.518 | 0.442 | 0.708 | 2.395 | 1.129 | 0.722 | 0.543 | 0.277 | 0 | 0.005 |
| Other Expenses
| 56.368 | 1.413 | 0 | 0.253 | -0.518 | -0.442 | 0.708 | -1.194 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 58.538 | 1.922 | 0.674 | 0.926 | 0.518 | 0.442 | 0.708 | 1.2 | 1.129 | 0.722 | 0.543 | 0.277 | 0 | 0.005 |
| Operating Income
| -56.125 | -0.697 | -0.674 | -0.926 | -0.518 | -0.442 | -0.708 | -1.2 | -1.129 | -0.722 | -0.543 | -0.277 | -0 | -0.005 |
| Operating Income Ratio
| -16.731 | -0.407 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.823 | -1.906 | -0.294 | -1.935 | 0.596 | 0.706 | -1.187 | 0.07 | 0.392 | 0.063 | 0.016 | 0.002 | 0 | 0 |
| Income Before Tax
| -52.302 | -2.603 | -0.968 | -2.861 | 0.078 | 0.264 | -1.895 | -1.131 | -0.738 | -0.659 | -0.527 | -0.276 | -0 | -0.005 |
| Income Before Tax Ratio
| -15.592 | -1.521 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.55 | -2.273 | 0 | -1.443 | 0.08 | 0.042 | 1.32 | 0.104 | 0.083 | -0.125 | -0.016 | 0.003 | 0 | 0 |
| Net Income
| -51.752 | -0.33 | -0.968 | -2.861 | 0.078 | 0.264 | -3.215 | -1.235 | -0.821 | -0.534 | -0.512 | -0.276 | -0 | -0.005 |
| Net Income Ratio
| -15.428 | -0.193 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -3.43 | -0.06 | -0.27 | -0.71 | 0.019 | 0.063 | -0.77 | -0.12 | -0.055 | -0.036 | -0.034 | -0.019 | 0 | -0 |
| EPS Diluted
| -3.43 | -0.06 | -0.27 | -0.71 | 0.019 | 0.063 | -0.77 | -0.12 | -0.055 | -0.036 | -0.034 | -0.019 | 0 | -0 |
| EBITDA
| -56.125 | -0.697 | -0.674 | -0.926 | -0.518 | 0.664 | -0.632 | -0.535 | -0.738 | -0.659 | -0.527 | -0.277 | -0 | -0.005 |
| EBITDA Ratio
| -16.731 | -0.407 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |